QuidelOrtho Corporation (QDEL) P/E Ratio History
Historical price-to-earnings valuation from 1992 to 2023
Loading P/E history...
QDEL Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, QuidelOrtho Corporation (QDEL) trades at a price-to-earnings ratio of -0.6x, with a stock price of $10.77 and trailing twelve-month earnings per share of $-17.76.
The current P/E is 101% below its 5-year average of 46.7x. Over the past five years, QDEL's P/E has ranged from a low of 3.8x to a high of 384.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, QDEL trades at a 103% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, QDEL trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our QDEL DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
QDEL P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $17B | 30.5 | - | -25% | |
| $7B | 9.2Lowest | - | +143%Best | |
| $45B | 43.7 | 3.06 | +23% | |
| $12B | 29.8 | - | +1% | |
| $151B | 11.4 | 0.38Best | +134% | |
| $124B | 34.9 | - | -5% | |
| $56B | 26.3 | 1.59 | -1% | |
| $21B | 24.7 | - | +18% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
QDEL Historical P/E Data (1992–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q3 | Sun Oct 01 2023 00:00:00 GM | $73.04 | $0.19 | 384.4x | +302% |
| FY2023 Q2 | Sun Jul 02 2023 00:00:00 GM | $82.86 | $0.66 | 125.5x | +31% |
| FY2023 Q1 | Sun Apr 02 2023 00:00:00 GM | $89.09 | $1.82 | 49.0x | -49% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $85.67 | $12.41 | 6.9x | -93% |
| FY2022 Q3 | Sun Oct 02 2022 00:00:00 GM | $71.48 | $18.81 | 3.8x | -96% |
| FY2022 Q2 | Sun Jul 03 2022 00:00:00 GM | $97.11 | $23.61 | 4.1x | -96% |
| FY2022 Q1 | $112.46 | $23.70 | 4.7x | -95% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $134.99 | $16.47 | 8.2x | -91% |
| FY2021 Q3 | $141.15 | $20.40 | 6.9x | -93% | |
| FY2021 Q2 | Wed Jun 30 2021 00:00:00 GM | $128.12 | $20.65 | 6.2x | -94% |
| FY2021 Q1 | Wed Mar 31 2021 00:00:00 GM | $127.93 | $21.75 | 5.9x | -94% |
| FY2020 Q4 | $179.65 | $18.59 | 9.7x | -90% |
Average P/E for displayed period: 95.7x
See QDEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs QDEL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare QDEL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonQDEL — Frequently Asked Questions
Quick answers to the most common questions about buying QDEL stock.
Is QDEL stock overvalued or undervalued?
QDEL trades at -0.6x P/E, below its 5-year average of 46.7x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does QDEL's valuation compare to peers?
QuidelOrtho Corporation P/E of -0.6x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is QDEL's PEG ratio?
QDEL PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1992-2023.